BORALDI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 18.597
AS - Asia 7.780
EU - Europa 6.995
SA - Sud America 1.119
Continente sconosciuto - Info sul continente non disponibili 292
AF - Africa 174
OC - Oceania 25
Totale 34.982
Nazione #
US - Stati Uniti d'America 18.135
SG - Singapore 2.527
GB - Regno Unito 2.218
CN - Cina 1.942
IT - Italia 1.525
HK - Hong Kong 897
BR - Brasile 861
VN - Vietnam 777
DE - Germania 775
SE - Svezia 631
BD - Bangladesh 465
FI - Finlandia 454
RU - Federazione Russa 297
KR - Corea 281
UA - Ucraina 250
CA - Canada 232
FR - Francia 227
TR - Turchia 202
IN - India 150
ID - Indonesia 120
BG - Bulgaria 111
AR - Argentina 96
MX - Messico 81
ES - Italia 79
JP - Giappone 76
BE - Belgio 70
IQ - Iraq 61
ZA - Sudafrica 59
NL - Olanda 58
PL - Polonia 47
CO - Colombia 45
IE - Irlanda 39
CR - Costa Rica 36
AE - Emirati Arabi Uniti 35
PK - Pakistan 35
EC - Ecuador 29
MA - Marocco 29
AT - Austria 28
CZ - Repubblica Ceca 27
LT - Lituania 26
MY - Malesia 26
CL - Cile 23
PH - Filippine 23
AU - Australia 22
CH - Svizzera 18
HU - Ungheria 18
VE - Venezuela 18
RO - Romania 16
DZ - Algeria 15
JM - Giamaica 15
HN - Honduras 14
PE - Perù 14
SA - Arabia Saudita 14
JO - Giordania 13
TH - Thailandia 13
UZ - Uzbekistan 13
BO - Bolivia 12
GT - Guatemala 12
KZ - Kazakistan 12
PY - Paraguay 12
GR - Grecia 11
IL - Israele 11
KE - Kenya 11
BZ - Belize 10
TT - Trinidad e Tobago 10
AZ - Azerbaigian 9
IR - Iran 9
TN - Tunisia 9
DK - Danimarca 8
SK - Slovacchia (Repubblica Slovacca) 8
SV - El Salvador 8
BY - Bielorussia 7
EG - Egitto 7
NP - Nepal 7
PA - Panama 7
TW - Taiwan 7
AL - Albania 6
AO - Angola 6
ET - Etiopia 6
GE - Georgia 6
LB - Libano 6
PR - Porto Rico 6
PT - Portogallo 6
SN - Senegal 6
UY - Uruguay 6
AM - Armenia 5
BB - Barbados 5
BS - Bahamas 5
DO - Repubblica Dominicana 5
HR - Croazia 5
NO - Norvegia 5
OM - Oman 5
PS - Palestinian Territory 5
SI - Slovenia 5
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
EU - Europa 4
NI - Nicaragua 4
QA - Qatar 4
XK - ???statistics.table.value.countryCode.XK??? 4
Totale 34.618
Città #
Ashburn 2.663
Southend 1.586
Santa Clara 1.502
Singapore 1.462
Fairfield 1.394
Chandler 993
Hong Kong 879
San Jose 854
Woodbridge 829
Council Bluffs 732
Houston 697
Hefei 616
Ann Arbor 510
Jacksonville 471
Wilmington 469
Seattle 462
Cambridge 445
Nyköping 402
Chicago 385
Dearborn 378
Beijing 373
Helsinki 358
Modena 358
London 311
Los Angeles 305
Seoul 271
New York 264
Ho Chi Minh City 247
Hanoi 171
The Dalles 163
San Diego 144
São Paulo 128
Princeton 122
Buffalo 118
Milan 118
Izmir 107
Sofia 107
Bologna 103
Lauterbourg 99
Moscow 98
Dallas 89
Eugene 88
Salt Lake City 87
Jakarta 86
Munich 83
Columbus 80
Toronto 74
Frankfurt am Main 73
Brussels 65
Boardman 64
Bremen 64
Shanghai 63
Des Moines 61
Reggio Emilia 61
Tokyo 55
Orem 53
Atlanta 50
Redwood City 44
Elk Grove Village 43
Da Nang 42
Denver 42
Tampa 41
Rome 40
Falls Church 38
Brooklyn 37
Turin 37
Guangzhou 36
Mexico City 36
Norwalk 36
Grafing 35
Montreal 35
San Francisco 33
Phoenix 32
Warsaw 32
Boston 31
Porto Recanati 30
Dublin 28
Rio de Janeiro 28
Amsterdam 26
Haiphong 26
Johannesburg 26
Falkenstein 25
Manchester 25
Málaga 25
Dong Ket 23
Baghdad 22
Chennai 22
Mumbai 22
Nuremberg 22
San José 22
Brasília 21
Kent 21
Philadelphia 21
Miami 20
Verona 18
Belo Horizonte 17
Newark 17
Redondo Beach 17
Washington 17
Reading 16
Totale 24.117
Nome #
Exome sequencing and bioinformatic approaches reveals rare sequence variants involved in cell signalling and elastic fibre homeostasis: new evidence in the development of ectopic calcification 552
Metabolic reprograming shapes neutrophil functions in severe COVID-19 434
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. 430
Thymic maturation and programmed cell death 426
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 421
High speed flow cytometry allows the detection of circulating endothelial cells in hemangioblastoma patients 417
Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients 416
Cell-matrix interactions of in vitro human skin fibroblasts upon addition of hyaluronan 409
Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients? 403
Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential 397
Cytotoxic Evaluation of Elastomeric Dental Impression Materials on a Permanent Mouse Cell Line and on a Primary Human Gingival Fibroblast Culture 391
Abnormal phenotype of in vitro dermal fibroblasts from patients with pseudoxanthoma elasticum (PXE) 387
Adhesion and proliferation of human dermal fibroblasts on collagen matrix 384
Comparison of ex vivo and in vitro human fibroblast ageing models 382
Heparan sulfate affects elastin deposition in fibroblasts cultured from donors of different ages 382
Study of the potential citotoxicity of dental impression materials. 380
Fibroblast protein profile analysis highlights the role of oxidative stress and vitamin K recycling in the pathogenesis of pseudoxanthoma elasticum 378
Matrix gla protein and alkaline phosphatase are differently modulated in human dermal fibroblasts from PXE patients and controls 377
Matrix Gla Protein involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. 376
Changes in dermal fibroblasts from Abcc6-/- mice are present before and after the onset of ectopic tissue mineralization 369
A long-term study on female mice fed on a genetically modified soybean: effects on liver ageing. 360
Magnesium modifies the structural features of enzymatically mineralized collagen gels affecting the retraction capabilities of human dermal fibroblasts embedded within this 3D system 356
Heparan sulfates facilitate harmless amyloidogenic fibril formation interacting with elastin-like peptides 355
Impaired Mitochondrial Morphology and Functionality in Lonp1wt/- Mice 353
Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach 351
The skin equivalent model: developments and perspectives. 348
Fibroblast involvement in soft connective tissue calcification 345
Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations 345
Parameters of oxidative stress are present in the circulation of PXE patients 345
Sirtuin 3 interacts with Lon protease and regulates its acetylation status. 344
Identification of mineralized elastic fibers on wet samples by SEM 341
New insights into autophagic cell death in the gypsy moth Lymantria dispar: a proteomic approach 341
IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids 341
AN IN-VITRO MODEL OF CALCIFICATION FOR THE STUDY OF THE OSTEOGENIC POTENTIAL OF ADULT HUMAN DERMAL FIBROBLASTS. 339
Fibroblasts from patients affected by Pseudoxanthoma elasticum exhibit an altered PPi metabolism and are more responsive to pro-calcifying stimuli 339
Histology-directed and imaging mass spectrometry: An emerging technology in ectopic calcification 336
Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts 334
Ageing of connective tissues 330
Analisi della biocompatibilità dei materiali dentari da impronta 330
Ectopic calcification in β-thalassemia patients is associated with increased oxidative stress and lower MGP carboxylation 329
Antioxidant status in the circulation of patients with Pseudoxanthoma elasticum (PXE). 326
Pseudoxanthoma elasticum and reflectance confocal microscopy: report of two affected young sisters 325
Innovative Flow Cytometry Allows Accurate Identification of Rare Circulating Cells Involved in Endothelial Dysfunction 325
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparations 323
The Effects of Parenteral K1 Administration in Pseudoxanthoma Elasticum Patients Versus Controls. A Pilot Study 322
Donor's age and replicative senescence favour the in-vitro mineralization potential of human fibroblasts 319
Toward the Molecular Deciphering of Pomacea canaliculata Immunity: First Proteomic Analysis of Circulating Hemocytes 319
Relationship Between Mitochondrial Structure and Bioenergetics in Pseudoxanthoma elasticum Dermal Fibroblasts 318
Rare Co-occurrence of Beta-Thalassemia and Pseudoxanthoma elasticum: Novel Biomolecular Findings 316
New insights into Pseudoxanthoma elasticum pathogenesis by proteome analysis. 315
New insights on the pathogenesis of Pseudoxanthoma elasticum by proteome analysis. 314
Comparison of Fibroblasts from Patients Affected by Pseudoxanthoma elasticum (PXE) or by β-Thalassemia with (β-thal-PXE+) and without PXE-Like Clinical Manifestations (β-thal-PXE-) 314
DIFFERENTIALLY EXPRESSED PROTEINS IN FIBROBLASTS FROM Abcc6-/- AND Abcc6+/+ MICE HIGHLIGHT THE ROLE OF A LOCALLY ALTERED PHOSPHATE METABOLISM IN THE OCCURRENCE OF ECTOPIC CALCIFICATION 313
The effect of serum withdrawal on the protein profile of quiescent human dermal fibroblasts in primary cell culture 310
Impression Materials: A Comparison Of Their Biological Characteristics 309
The protein profile of fibroblasts: the role of proteomics. 309
New insights on the pathogenesis of clinical manifestations in Pseudoxathoma elasticum. 303
Interactions between elastin-like peptides and an insulating poly(ortho-aminophenol) membrane investigated by AFM and XPS 302
Response of confluent human dermal fibroblasts to serum deprivation investigated by proteome analysis. 301
THE ROLE OF DERMAL FIBROBLASTS IN THE DEVELOPMENT OF ECTOPIC CALCIFICATIONS 297
Structural characterization and biological properties of the amyloidogenic elastin-like peptide (VGGVG)3 293
Connective tissue and diseases: from morphology to proteomics towards the development of new therapeutic approaches. 292
Characterization of pseudoxanthoma elasticum-like lesions in the skin of patients with beta-thalassemia 290
Hyaluronan affects protein and collagen synthesis by in vitro human skin fibroblasts 289
Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early-stage NSCLC 288
Normal human dermal fibroblasts: Proteomic analysis of cell layer and culture medium 285
The biology of vascular calcification 285
Time-course of protective effects on the aorta wall by treatment with delapril, indapamide and their combination in stroke-prone spontaneously hypertensive rats (SHRsp) 283
Proteome analysis of dermal fibroblasts cultured in vitro from human healthy subjects of different ages 283
Peripapillary comet lesions and comet rain in PXE-related retinopathy 283
Pomacea canaliculata ampullar proteome: A nematode-based bio-pesticide induces changes in metabolic and stress-related pathways 283
Connective tissue in skin biopsies from patients suffering systemic sclerosis 282
Identification of heterozygote carriers in families with a recessive form of pseudoxanthoma elasticum (PXE) 281
The multifaceted complexity of genetic diseases: a lesson from pseudoxanthoma elasticum. 279
Is matrix GLA Protein (MGP) a key regulator of elastic fiber calcification? 271
THE ROLE OF VITAMIN K-DEPENDENT PROTEINS IN THE PATHOGENESIS OF PSEUDOXANTHOMA ELASTICUM 270
The mineralization process of insoluble elastin fibrillar structures: Ionic environment vs degradation 267
Cell behaviour and cell-matrix interactions of human palmar aponeurotic cells in vitro 260
A proteomic approach for investigating the aging process; the human fibroblast model. 259
VALUTAZIONE DELLA CITOTOSSICITA’ DEI MATERIALI DENTALI DA IMPRONTA 258
Fibroblasts from patients with beta-Thalassemia and Pseudoxanthoma elasticum-like clinical manifestations. 254
A case report of pseudoxanthoma elasticum with rare sequence variants in genes related to inherited retinal diseases 253
Apoptosis in the Extraosseous Calcification Process 249
On the pathogenesis of PXE-like clinical manifestations in Beta-thalassemic patients 248
Adaptive Optics Imaging in Patients Affected by Pseudoxanthoma Elasticum 248
Dermal Alterations in Clinically Unaffected Skin of Pseudoxanthoma elasticum Patients 248
Ultrastructural and morphometrical evaluations on normal human dermal connective tissue - The influence of age, sex and body region 247
Involvement of IGF-II receptors in the antioxidant and neuroprotective effects of IGF-II on adult cortical neuronal cultures 245
Pigment epithelial-derived factor: a new player in dermal elastic fibre calcification? 245
Age-related changes in the matrisome of the mouse skeletal muscle 245
The role of hypoxic condition on the protein profile profile of human fibroblasts 244
Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions 242
The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells 242
From Clinical Diagnosis to the Discovery of Multigene Rare Sequence Variants in Pseudoxanthoma elasticum: A Case Report 235
Phenotypic Features and Genetic Findings in a Cohort of Italian Pseudoxanthoma Elasticum Patients and Update of the Ophthalmologic Evaluation Score 233
Functional genomics: the PXE model 232
Oxidative stress is a key regulator of ectopic calcifications in beta-Thalassemia patients 230
The Role of Fibroblasts in Skin Homeostasis and Repair 227
Coquille d’oeuf in young patients affected with Pseudoxantoma elasticum 225
Validation of airway porcine epithelial cells as an alternative to human in vitro preclinical studies 219
Totale 31.645
Categoria #
all - tutte 127.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.839 0 0 0 181 95 126 153 129 250 182 473 250
2022/20232.641 279 318 207 292 283 395 61 299 263 23 119 102
2023/20241.365 42 86 99 126 330 141 107 169 37 32 45 151
2024/20255.923 265 61 113 382 1.023 762 429 411 583 431 709 754
2025/202610.509 672 492 783 1.062 1.614 665 1.255 475 1.110 927 733 721
2026/20273.332 324 651 780 1.577 0 0 0 0 0 0 0 0
Totale 34.982